InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Co-Founder, CEO Featured on Bell2Bell Podcast
August 19, 2021
Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, has announced that co-founder and CEO Kelsey Ramsden is featured on the latest episode of the Bell2Bell podcast. The Bell2Bell Podcast offers its listeners insightful interviews with executives of companies operating in fast-moving industries. During the episode, hosted […]
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Kelsey Ramsden, Co-Founder & CEO of Mind Cure Health Inc.
August 19, 2021
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) — via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Welcomes Digital Technology Expert in Development of Doctor-Patient SaaS Tech
August 17, 2021
Canada-based life sciences company Mind Cure Health is pursuing innovative technology and research solutions to improve mental health through technology The company is focused on developing digital therapeutics technology and researching psychedelic compounds The company’s proprietary software-as-a-service (SaaS) platform iSTRYM is designed to increase transparency and awareness between patients and therapists On the research side, […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Featured in Coverage of Investor Summit Group’s Q3 Virtual Event
August 13, 2021
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based psychedelic-assisted therapies globally. For more information, visit the company’s […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Bolsters its Advisory Board With The Appointment of Jerry White
August 13, 2021
Mind Cure Health Inc. announced Jerry White’s appointment into the company’s advisory board Mr. White brings a wealth of experience from his years of powering global movements and working with key leaders and personalities around the world MINDCURE forecasts that with Mr. White’s addition to the board, the company will be well-positioned to achieve bigger […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Names Digital Therapy Visionary as Tech Advisor
August 10, 2021
Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has announced that Dr. Ken Weingardt, CEO of Audacious Digital Health, will be serving as senior clinical technology advisor. Weingardt is a clinical psychologist and has served as senior clinical director at Pear Therapeutics. Specifically, Weingardt will […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Names Nobel Peace Prize Recipient as Company Advisor
August 4, 2021
Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has appointed Jerry White as a company advisor. A passionate activist, author and social entrepreneur, White is the recipient of numerous human rights and leadership awards, including sharing the Nobel Peace Prize in 1997. In his […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Launches Second Stage of Manufacturing of Ibogaine for Clinical Research
July 30, 2021
The company has filed patent applications for two routes of chemical synthesis of ibogaine – offering potential advantages of improved isomeric purity, chiral purity, and easily isolated intermediate compounds Preliminary data indicates that the drug shows promise as a treatment for neuropathic pain and migraines, as well as the treatment of addiction The company is […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Is ‘One to Watch’
July 28, 2021
MINDCURE’s proprietary digital therapeutics technology platform creates a high barrier to entry for any potential competitors The company maintains active partnerships with growing firms in AI, technology, and mental health MINDCURE’s world-class scientific discovery team has decades of combined experience in researching and commercializing pharmaceutical grade drugs The company has demonstrated a clear path to […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Manufacture of Synthetic Ibogaine Moves to Second Stage
July 27, 2021
Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has begun the second stage of manufacturing pharmaceutical-grade ibogaine to be used in clinical research. According to the announcement, this stage will focus on assessing the quality of MINDCURE’s synthetic ibogaine when produced at scale to […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Files Two Patents for Fully Synthetic Routes to Create Ibogaine Psychedelic Compound
July 13, 2021
Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has filed two provisional patent applications with the United States Patent and Trademark Office (“USPTO”) for innovative processes for synthesizing ibogaine. According to the announcement, MINDCURE’s pharmaceutical-grade ibogaine would provide researchers access to a sustainable, high-quality, reliable […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Featured in Virtual Coverage of LD Micro’s Invitational XI
June 8, 2021
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based psychedelic-assisted therapies globally. To register for LD Micro’s Invitational […]
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Strategic Equity Investment in Psychedelic Journey Center
April 9, 2021
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology for psychedelic therapy, has announced a follow-up strategic equity investment in ATMC Journey Centers Inc. (“ATMA”), the first government-approved psychedelic journey center in Canada. Earlier this year, MCUR had signed a letter of intent, securing 13% ownership in ATMA; this […]
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Featured in Virtual Coverage of Benzinga’s Global Small Cap Conference
December 8, 2020
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) exists as a response to the current mental health crisis and urgent calls for effective treatments. Mind Cure believes in the need to reinvent the mental health care model for patients and practitioners to allow psychedelics to advance into common and accepted care. Mind Cure is focused […]